Key Psychosis-Spectrum Glutamate Imaging and Cannabis Signals
Comments Off on Key Psychosis-Spectrum Glutamate Imaging and Cannabis Signals
June 30, 2026
This June 2026 digest highlights the psychosis-spectrum glutamate imaging cannabis study alongside a CBD case report in traumatic brain injury and preclinical neuroprotection research. These findings emphasize careful interpretation of cannabis brain…
NfL and GFAP quantification and associations with mental health in recreational cannabis users-Results from the Swiss study on recreational cannabis access via pharmacies.
Comments Off on NfL and GFAP quantification and associations with mental health in recreational cannabis users-Results from the Swiss study on recreational cannabis access via pharmacies.
April 27, 2026
A Swiss study measuring cannabis brain damage biomarkers study results in 331 regular users found no evidence of nerve damage and unexpectedly lower levels of brain injury markers. These objective biomarker findings challenge assumptions about cannabis…